Effects of low and high concentrations of antitumour drug taxol in anaplastic thyroid cancer cells

Experimental Oncology

Volumn 31, Issue 1, 2009, Pages 16-21

  Pushkarev, V M ^a   Starenki, D V ^b   Saenko, V A ^c   Yamashita, S ^c   Kovzun, O I ^a   Popadiuk, I D ^a   Pushkarev, V V ^a   Tronko, M D ^a  

^a V P Komisarenko Institute of Endocrinology and Metabolism of the Ukraine Academy of Medical Sciences   (Ukraine)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

Accelerated senescence; Anaplastic cancer; Apoptosis; Cell cycle; Mitochondrial membrane potential; Taxol; Thyroid

Indexed keywords

CASPASE; PACLITAXEL; ANTINEOPLASTIC AGENT;

ANAPLASTIC CARCINOMA; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MICROSCOPY; MITOCHONDRIAL MEMBRANE POTENTIAL; SENESCENCE; THYROID CANCER; WESTERN BLOTTING; CARCINOMA; CELL CYCLE; DRUG EFFECT; METABOLISM; THYROID TUMOR; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA; CASPASES; CELL CYCLE; CELL LINE, TUMOR; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; PACLITAXEL; THYROID NEOPLASMS;

EID: 65549149546     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kingston DGI. The shape of things to come: structural and synthetic studies of taxol and related compounds. Phytochemistry 2007; 68: 1844-1854
2. Ain KB, Egorin MJ, DeSimone PA. Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid 2000; 10: 587-594
3. Pushkarev VM, Starenki DV, Saenko VA, et al. Molecular mechanism of the effects of low concentrations of taxol in anaplastic thyroid cancer cells. Endocrinology 2004; 145: 3143-3152
4. Torres K, Horwitz SB. Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res 1998; 58: 3620-3626 (Pubitemid 28376560)
5. Gustafson DL, Long ME, Zirrolli JA, et al. Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LCMS assay. Cancer Chemother Pharmacol 2003; 52: 159-166
6. Xu G, Pan J, Martin C, Yeung S-CJ. Angiogenesis inhibition in the in vivo antineoplastic effect of manumycin and paclitaxel against anaplastic thyroid carcinoma. J Clin Endocrinol Metab 2001; 86: 1769-1777
7. Pineiro D , Martín ME, Guerra N, et al. Calpain inhibition stimulates caspase-dependent apoptosis induced by taxol in NIH3T3 cells. Exp Cell Res 2007; 313: 369-379 (Pubitemid 46048822)
8. Stassi G, Todaro M, Zerilli M, et al. Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10. Cancer Res 2003; 63: 6784-6790 (Pubitemid 37322959)
9. Scaduto RC, Grotyohann LW. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys J 1999; 76: 469-477 (Pubitemid 29202474)
10. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92: 9363-9367
11. Podtcheko A, Namba H, Saenko V, et al. Radiationinduced senescence-like terminal growth arrest in thyroid cells. Thyroid 2005; 15: 306-313 (Pubitemid 40677400)
12. Roninson IB, Broude EV, Chang B-D. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Update 2001; 4: 303-313
13. Demidenko ZN, Kalurupalle S, Hanko C, et al. Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis. Oncogene 2008; 27: 4402-4410
14. Klein LE, Freeze BS, Smith AB 3rd, Horwitz SB. The microtubule stabilizing agent discodermolide is a potent inducer of accelerated cell senescence. Cell Cycle 2005; 4: 501-507
15. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nature Rev Mol Cell Biol 2007; 8: 729-740
16. INK4a is required for human fibroblast senescence and for limiting ras-induced epithelial cell proliferation. Exp Cell Res 2004; 292: 151-156
17. Shapiro GI. Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol 2006; 24: 1770-1783 (Pubitemid 46628473)